Richard W DeClue

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Prognostic Factors

Metastatic Colorectal Cancer

Ejection Fraction

Top Venues

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Richard W DeClue, Maxine D Fisher, Kyna Gooden, Mark S Walker, Trong Kim Le
Real-world outcomes in metastatic HR+/HER2-, HER2+ and triple negative breast cancer after start of first-line therapy. Future oncology (London, England) (2023)
Whitney Rhodes, Richard W DeClue, Neil A Accortt, Ran Jin, Darcie Sandschafer, Debra Wertz, Kashyap Patel
Real-world use of bevacizumab-awwb, a bevacizumab biosimilar, in US patients with metastatic colorectal cancer. Future oncology (London, England) 17 (36) (2021)
Xinke Zhang, Richard W DeClue, Lisa Herms, Mo Yang, Vivek Pawar, Elizabeth T Masters, Mary Ruisi, Kevin Chin, Vamsidhar Velcheti
Real-world treatment patterns and outcomes in PD-L1-positive non-small cell lung cancer. Immunotherapy 13 (18) (2021)